E. Allan

Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding*

Magnar Bjørås, Bjørn Dalhus, Inger Sandlie, 2014, The Journal of Biological Chemistry.

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab

Benjamin P. Cossins, T. Ceska, Anthony H Keeble, 2017, The Journal of Biological Chemistry.

Extending Serum Half-life of Albumin by Engineering FcRn Binding

Inger, J. Andersen, B. Dalhus, 2014 .

Investigating allostery in IgE-Fc using a panel of anti-IgE antibodies

E. Allan, 2017 .

Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.

Chin Wee Tan, Dharmesh D. Bhuva, Eric C Greenwald, 2023, Cell chemical biology.